Innovative Drug Discovery and Development
Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.
Artificial Intelligence Shakes Up Drug Discovery
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Drs. Andy Phillips (C4 Therapeutics) and Michael “Mick” Soth (MD Anderson IACS) will speak on Targeted Protein Degradation and Targeting Glutaminase Addition in Cancer: Development of a GLS1 Inhibitor, respectively. […]Find out more »
esqLABS, in collaboration with the University of Houston, College of Pharmacy, is running two hands-on PK-Sim® & MoBi® workshops on PBPK and PBPK-based QSP on Monday and Tuesday 16th and 17th of March 2020 (pre ASCPT) […]Find out more »
Houston, Texas 77204 United States
Please save the date for this exciting conference and stay tuned for speaker updates. James Inglese, NIH/NCATS is confirmed.Find out more »